Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Pfizer
|
| gptkbp:acquisitionYear |
2016
|
| gptkbp:focusesOn |
dermatology
small-molecule therapeutics |
| gptkbp:founded |
2002
|
| gptkbp:founder |
gptkb:Andrei_Kogan
gptkb:Jacob_Plattner |
| gptkbp:headquarters_location |
gptkb:Palo_Alto,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Anacor Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:crisaborole
gptkb:tavaborole |
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:ANAC
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
http://www.anacor.com
|
| gptkbp:bfsParent |
gptkb:Pfizer
|
| gptkbp:bfsLayer |
4
|